Tus kws kho mob
P47-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1291 - 1300 ntawm 4374
Tus kws kho mob
P48-22 Reimbursement Policy Update for -CO and -CQ Modifiers for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P49-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tus kws kho mob
2022 August Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tus kws kho mob
QP61-22 Free Continuing Education for Mental Health Providers through 12/31/22
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2022
Tus kws kho mob
QP62-22 Commercial Pharmacy Benefit Exclusion for Propel®, Propel Mini®, Sinuva®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2022
Tus kws kho mob
QP63-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Ryplazim® (plasminogen, human-tvmh)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2022
Tus kws kho mob
QP55-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 13, 2022
Tus kws kho mob
QP56-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Cibinqo™ (abrocitinib)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 13, 2022
Tus kws kho mob
QP57-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Pyrukynd® (mitapivat)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 13, 2022